Cephalon, LLC drugs
6 results
Actiq (fentanyl citrate)
(Fentanyl Citrate)Cephalon, LLC
Usage: ACTIQ is indicated for managing breakthrough pain in cancer patients aged 16 and older who are already tolerant to around-the-clock opioid therapy for persistent cancer pain. It is not for use in opioid non-tolerant patients or for acute or postoperative pain management.
Granix (tbo-filgrastim)
(tbo-filgrastim)Cephalon, LLC
Usage: GRANIX is indicated for reducing the duration of severe neutropenia in adults and pediatric patients 1 month and older with non-myeloid malignancies undergoing myelosuppressive anticancer treatment that may cause clinically significant febrile neutropenia.
Herzuma (trastuzumab)
(TRASTUZUMAB)Cephalon, LLC
Usage: HERZUMA is indicated for adults with HER2 overexpressing breast cancer in adjuvant settings and for metastatic breast cancer, either in combination with specific chemotherapy regimens or as a single agent. It is also indicated for HER2 overexpressing metastatic gastric cancer in combination with cisplatin and capecitabine or 5-fluorouracil.
Provigil (modafinil)
(Modafinil)Cephalon, LLC
Usage: PROVIGIL is indicated for improving wakefulness in adults with excessive sleepiness due to narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). It is not a treatment for the underlying causes of OSA, and CPAP should be prioritized if appropriate.
Synribo (omacetaxine mepesuccinate)
(Omacetaxine Mepesuccinate)Cephalon, LLC
Usage: SYNRIBO is indicated for adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) who have resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKIs).
Trisenox (arsenic trioxide)
(Arsenic Trioxide)Cephalon, LLC
Usage: TRISENOX is indicated for adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) in combination with tretinoin, and for inducing remission and consolidation in patients with relapsed or refractory APL, both characterized by t(15;17) translocation or PML/RAR-alpha gene expression.